NCT05107596View on ClinicalTrials.gov

Evaluation of CCR2 in Patients Post Myocardial Infarction

PHASE1RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 24, 2018

Primary Completion Date

November 24, 2025

Study Completion Date

November 24, 2025

Conditions
Heart Diseases
Interventions
DRUG

64Cu-DOTA-ECL1i

Inject PET Radioisotope for imaging

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT05107596 - Evaluation of CCR2 in Patients Post Myocardial Infarction | Biotech Hunter | Biotech Hunter